Vimarsana
Biggest News Aggregation in the World

Michael Kaplitt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michael Kaplitt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michael Kaplitt Today - Breaking & Trending Today

NYC man with disabled parking permit has car confiscated - Vimarsana News

NYC man with disabled parking permit has car confiscated

Jonathan Steinberg, who has Parkinson's disease, faces administrative nightmare that includes years of fighting off thousands of dollars in parking tickets.

Source: nypost.com
LEXEO Therapeutics to Present New Clinical Data from its - Vimarsana News

LEXEO Therapeutics to Present New Clinical Data from its

NEW YORK, Oct. 05, 2022 (GLOBE NEWSWIRE) -- LEXEO Therapeutics, Inc. (LEXEO), a clinical-stage biotech company advancing a pipeline of adeno-associated...

$8.9M ASAP/Fox Foundation Grant Funds Parkinson's Gut-Brain Connection Study - Vimarsana News

$8.9M ASAP/Fox Foundation Grant Funds Parkinson's Gut-Brain Connection Study

A 3-year, $8.9 million grant is funding a research study on how abnormal protein aggregates may spread from the gut to the brain to drive the early stages of Parkinson's disease.

Researchers receive $8.9 million grant to study the gut-brain connection in Parkinson's disease - Vimarsana News

Researchers receive $8.9 million grant to study the gut-brain connection in Parkinson's disease

Dr. Michael Kaplitt, a professor of neurological surgery at Weill Cornell Medicine and a longtime leader in developing cutting-edge surgical therapies for movement disorders, leads a team that has been awarded a three-year, $8.9 million grant from the Aligning Science Across Parkinson's (ASAP) initiative.

$9M grant funds study of gut-brain connection in Parkinson's - Vimarsana News

$9M grant funds study of gut-brain connection in Parkinson's

Dr. Michael Kaplitt, a professor of neurological surgery at Weill Cornell Medicine and a longtime leader in developing cutting-edge surgical therapies